MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SpinalMotion, developer of investigational artificial discs for treating patients with degenerative disc disease (DDD), today announced that it has completed enrollment of its cervical clinical trial. The trial, evaluating the Kineflex®/C cervical disc implant, is being conducted under an Investigational Device Exemption (IDE). Enrollment in the company’s first IDE clinical trial, evaluating the Kineflex® lumbar disc implant, was completed last year.
